This systematic review provides a high-quality, comprehensive summary of recommendations on hypertension (HT) and type 2 diabetes mellitus (T2DM), accentuating patient blood pressure, HbA1c levels, patterns of drug treatment, management, and screening of these diseases. The overall objective of the revie...
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and mad...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It
focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose
levels, and identifying and managing long-term complications....
The previous treatment guide for type 2 diabetes was prepared by the Estonian Society of Endocrinology
led in 2016 and discussed type 2 diabetes screening, diagnosis and
pharmacological treatment (1). The guideline was prepared as an expert opinion/consensus and no
followed the agreed methodology, which ...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. In December 2020, we made minor changes to the ...
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 2/prevention & control,
Patient Education as Topic,
Glucose/analysis,
Eye-Tracking Technology,
Dipeptidyl-Peptidase IV Inhibitors/therapeutic use,
Pioglitazone/therapeutic use,
Sulfonylurea Compounds/therapeutic use,
Platelet Aggregation Inhibitors/therapeutic use
Diabetes is a chronic, progressive disease characterized by elevated blood glucose levels. Diabetes can lead to complications such as cardiovascular disease, damage to eyes, kidneys and nerves, and premature death. Globally, more than 400 million adults live with diabetes, and diabetes directly caused 1....
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus, Type 2/drug therapy,
Hypoglycemic Agents/administration & dosage,
Glycemic Index,
Clinical Decision-Making,
Patient-Centered Care,
Biomarkers/blood,
Diabetes Mellitus, Type 2/blood,
Life Expectancy,
Fructosamine/blood,
Glycated Hemoglobin/analysis